colorectal-cancer

Documents about colorectal-cancer

• Ent-Atisane and 3,4-seco-atisane diterpenoids from Croton crocodilorum roots and their antiproliferative effect on human colorectal cancer cells#124544HAL (France)
• Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment#146456ClinicalTrials.gov
• Visceral and subcutaneous adipose stem cells modulate colorectal cancer cell progression: direct and indirect contact distinctly accelerate tumor aggressiveness.#148381NCBI PubMed Central
• Survival prediction of colorectal cancer using 101 machine learning methods based on immune-related genes: A machine learning study.#227769NCBI PubMed Central
• Replication Data for: "Colorectal cancer trends in Chile: a Latin-American country with marked socioeconomic inequities"#276427Repositorio de datos de investigación de la Universidad de Chile Dataverse OAI Archive
• The rapid surge of colorectal cancer in children and young adults: a 22-year analysis of the CDC WONDER database.#285156NCBI PubMed Central
• Postoperative dynamics of inflammatory markers in patients with uncomplicated recovery after colorectal cancer surgery: a preliminary inflammatory benchmarks study.#322921NCBI PubMed Central
• Elucidating the anti-colorectal cancer mechanism of Physalis Calyx seu Fructus extract via mass spectrometry-molecular networking and bioinformatics.#327274NCBI PubMed Central
• Cost-Effectiveness and Cost-Utility of a Colon Capsule Endoscopy in a Population-Based Screening Program for Colorectal Cancer#329347bioRxiv / medRxiv
• A post-discharge homecare journey map for patients with colorectal cancer living with a permanent stoma: A qualitative study.#335054NCBI PubMed Central
• A post-discharge homecare journey map for patients with colorectal cancer living with a permanent stoma: A qualitative study.#338843PubMed
• Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell–like phenotype#340173IRIS
• Independent prognostic value of tumor deposits in stage III colorectal cancer: a large-scale systematic review and meta-analysis.#360758NCBI PubMed Central
• KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors#414486ClinicalTrials.gov
• Novel adenoma-immune phenotypes are associated with risk of metachronous polyps and colorectal cancer in a bowel screening cohort#414789Europe PMC
• Integrated single-cell and spatial transcriptomic analyses identify TRIP6 as a prognostic and EMT-associated biomarker in colorectal cancer.#433875NCBI PubMed Central
• A matter of trust - patient's views on decision making in colorectal cancer#445538Griffith Research Online
• Construction of prognostic models for colorectal cancer based on the perioperative modified Gustave Roussy Immune Score and machine learning.#455516NCBI PubMed Central
• Association of postoperative delayed bowel function recovery with weight and muscle loss at 6 months in colorectal cancer patients.#479214NCBI PubMed Central
• Combining Epigenetic And Immune Therapy to Beat Cancer.#668813ClinicalTrials.gov
• Urinary metabolomics may improve prediction of overall survival beyond tumor stage in colorectal cancer: results from the ColoCare study.#785587NCBI PubMed Central
• Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors#411401ClinicalTrials.gov
• A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body#804452ClinicalTrials.gov
• Cure frailty models for survival data : application to recurrences for breast cancer and to hospital readmissions for colorectal cancer#391785HAL Science
• mFOLFOX6 + Bevacizumab + PD-1 Monoclonal Antibody Vs. mFOLFOX6 in Locally Advanced pMMR/MSS CRC#28309ClinicalTrials.gov
• Evaluation of nano-curcumin oral formulation efficacy in prevention of chemotherapy-induced adverse reactions in metastatic colorectal cancer patients.#67522NCBI PubMed Central
• Optimizing colorectal cancer screening through polygenic risk score-based risk stratification: evidence from a population-based cohort and screening trial.#143513NCBI PubMed Central
• Artificial intelligence-powered H&E-based quantification of spatial tumor-infiltrating lymphocyte distribution identifies prognostic immune niches in colorectal cancer.#156980NCBI PubMed Central
• Identification and Validation of Mitophagy-Related Biomarkers in Colorectal Cancer: An Integrated Analysis of Single-Cell Transcriptome and Mendelian Randomization.#174514NCBI PubMed Central
• [Multi-omics integration deciphers immune-metabolic heterogeneity in colorectal cancer: a prognostic model and therapeutic strategies targeting ANGPTL4/FABP4/RBP7].#236057NCBI PubMed Central
• Single Cell Analysis of Oncogenic Signalling in Intestinal Organoids#279801edoc-Server
• High glucose enhances N(ε)-(carboxymethyl)lysine (CML)-induced colorectal cancer progression via the ANO6/Smad2/3-E-cadherin signaling.#295291NCBI PubMed Central
• The experiences of a structured pelvic floor rehabilitation program in colorectal cancer survivors with low anterior resection syndrome: A qualitative study.#320403NCBI PubMed Central
• Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors#326130HAL (France)
• Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study#326132HAL (France)
• Health-related quality of life associated with fruquintinib in patients with metastatic colorectal cancer: Results from the FRESCO-2 study#326135HAL (France)
• Tertiary Lymphoid Structures as Predictors of Recurrence in Colorectal Cancer: Development and Validation of a Machine Learning-Based Scoring Model.#422930NCBI PubMed Central
• Subtype-Specific Alterations in Copper Trafficking Associated with KRAS Mutations in Isogenic Colorectal Cancer Cell Lines#428771Springer Nature OA
• Machine learning to develop and validate a model for predicting the risk of lymph node metastasis in colorectal cancer patients.#430807NCBI PubMed Central
• From Germline Variants to Tumor Outcome: GWAS-Based Functional Genomics Prioritizes Colorectal Cancer Susceptibility Genes and Links SMAD9 to Prognosis.#476905NCBI PubMed Central
• Identification and validation of a previously missed mutational signature in colorectal cancer#484945Europe PMC
• Database Searches For The Therapeutic Potential of Antibody-Drug Conjugates In Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis#628353Borealis Dataverse OAI Archive
• More is not always better: higher lymph node yield is not associated with improved survival in stage I-III colorectal cancer.#645380NCBI PubMed Central
• Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases#648645SUNScholar
• Body mass index, adjuvant chemotherapy, toxicity, and survival in non-metastatic colorectal cancer: an individual participant data meta-analysis (OCTOPUS)#676467Europe PMC
• Early DiAgnosis Real-Time Healthcare System for CANcer Trial#805294ClinicalTrials.gov
• Vandetanib-eluting Radiopaque Embolic Beads in Patients With Resectable Liver Malignancies#825248ClinicalTrials.gov
• Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI#827792ClinicalTrials.gov
• Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery#800721ClinicalTrials.gov
• A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies#813349ClinicalTrials.gov